{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0210","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0210","name":[{"text":"Doses 1 and 2 of Recombvx at ages 11-15 years with â‰¥ 4 mo interval = series complete. \nEvaluation_Test_Type: Interval: At Minimum\nGeneral_Description: This test case describes when dose #2 of the Hep B Recombivax vaccine is administered at an interval of 6 months from dose #1  to a child age 12 years, that dose is considered to be valid.  The series is complete."}],"gender":"female","birthDate":"2007-08-23"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0210-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"43","display":"RECOMBIVAX-ADULT"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-ADULT"}]},"patient":{"reference":"Patient/2013-0210"},"date":"2020-02-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0210-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"43","display":"RECOMBIVAX-ADULT"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-ADULT"}]},"patient":{"reference":"Patient/2013-0210"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}